Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
Julie C. Ullman, Annie Arguello, Jennifer A. Getz, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 545
Closed Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Strategies for delivering therapeutics across the blood–brain barrier
Georg C. Terstappen, Axel H. Meyer, Robert D. Bell, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 5, pp. 362-383
Closed Access | Times Cited: 709
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S. Kariolis, Robert C. Wells, Jennifer A. Getz, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 545
Closed Access | Times Cited: 252
Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Joseph W. Lewcock, Kai Schlepckow, Gilbert Di Paolo, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 801-821
Open Access | Times Cited: 175
Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic
Todd Logan, Matthew Simon, Amit Kumar Rana, et al.
Cell (2021) Vol. 184, Iss. 18, pp. 4651-4668.e25
Open Access | Times Cited: 146
A Historical Review of Brain Drug Delivery
William M. Pardridge
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 128
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Bettina van Lengerich, Lihong Zhan, Dan Xia, et al.
Nature Neuroscience (2023)
Open Access | Times Cited: 128
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Jifei Miao, Haixia Ma, Yang Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 87
Engineered Nanoerythrocytes Alleviate Central Nervous System Inflammation by Regulating the Polarization of Inflammatory Microglia
Na Yin, Yuzhen Zhao, Chang‐Hua Liu, et al.
Advanced Materials (2022) Vol. 34, Iss. 27
Closed Access | Times Cited: 75
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia
Dan Xia, Steve Lianoglou, Thomas Sandmann, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 71
Strategies for non-viral vectors targeting organs beyond the liver
Jeonghwan Kim, Yulia Eygeris, Renee C. Ryals, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 4, pp. 428-447
Closed Access | Times Cited: 53
Complement in the Brain: Contributions to Neuroprotection, Neuronal Plasticity, and Neuroinflammation
Suzanne S. Bohlson, Andrea J. Tenner
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 431-452
Open Access | Times Cited: 46
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 760
Closed Access | Times Cited: 19
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
Josephine H Pedder, Adam M. Sonabend, Michael D Cearns, et al.
The Lancet Neurology (2025)
Closed Access | Times Cited: 3
Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human
Wandong Zhang, Qing Yan Liu, Arsalan S. Haqqani, et al.
Fluids and Barriers of the CNS (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 126
Central nervous system delivery of molecules across the blood-brain barrier
Fabien Gosselet, Rodrigo Azevedo Loiola, Anna Roig, et al.
Neurochemistry International (2021) Vol. 144, pp. 104952-104952
Open Access | Times Cited: 88
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
Joshua R. D. Pearson, Stefania Cuzzubbo, Simon McArthur, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 84
Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles
Krzysztof Kucharz, Kasper Kristensen, Kasper Bendix Johnsen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 82
Sphingosine 1‐Phosphate Liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma Tumors
Yang Liu, Xiao Wang, Jing Li, et al.
Advanced Materials (2021) Vol. 33, Iss. 30
Closed Access | Times Cited: 64
Current directions in tau research: Highlights from Tau 2020
Claire E. Sexton, Heather M. Snyder, Dirk Beher, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 5, pp. 988-1007
Open Access | Times Cited: 59
The barrier and interface mechanisms of the brain barrier, and brain drug delivery
Shanshan Zhang, Lin Gan, Fengye Cao, et al.
Brain Research Bulletin (2022) Vol. 190, pp. 69-83
Open Access | Times Cited: 56
Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia
Matthew Simon, Todd Logan, Sarah L. DeVos, et al.
Trends in Cell Biology (2022) Vol. 33, Iss. 4, pp. 324-339
Open Access | Times Cited: 55
Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme
Annie Arguello, Cathal Mahon, Meredith Calvert, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 3
Open Access | Times Cited: 53
A Sub-Nanostructural Transformable Nanozyme for Tumor Photocatalytic Therapy
Xi Hu, Nan Wang, Xia Guo, et al.
Nano-Micro Letters (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 39
CD98hc is a target for brain delivery of biotherapeutics
Kylie S. Chew, Robert C. Wells, Arash Moshkforoush, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 11, pp. 1048-1060
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top